Synbiotic Bacillus megaterium DSM 32963 and n-3 PUFA Salt Composition Elevates Pro-Resolving Lipid Mediator Levels in Healthy Subjects: A Randomized Controlled Study
Nutrients · 2024
DOI: 10.3390/nu16091354 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2024. Verfasst von Bodo Speckmann und 6 weiteren Autor:innen. Beteiligte Einrichtung: Evonik Operations GmbH, Rodenbacher Chaussee 4, 63457 Hanau, Germany. Hauptthemen laut MEDLINE: Bacillus megaterium, Fatty Acids, Omega-3, Synbiotics, Eicosapentaenoic Acid. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Evonik Operations GmbH.
Abstract (Originalsprache)
Beneficial health effects of omega-3 polyunsaturated fatty acids (n-3 PUFA) are partly attributed to specialized pro-resolving mediators (SPMs), which promote inflammation resolution. Strategies to improve n-3 PUFA conversion to SPMs may, therefore, be useful to treat or prevent chronic inflammatory disorders. Here, we explored a synbiotic strategy to increase circulating SPM precursor levels. Healthy participants (n = 72) received either SynΩ3 (250 mg eicosapentaenoic acid (EPA) plus docosahexaenoic acid (DHA) lysine salts; two billion CFU Bacillus megaterium; n = 23), placebo (n = 24), or fish oil (300 mg EPA plus DHA; N = 25) capsules daily for 28 days in a randomized, double-blind placebo-controlled parallel 3-group design. Biomarkers were assessed at baseline and after 2 and 28 days of intervention. The primary analysis involved the comparison between SynΩ3 and placebo. In addition, SynΩ3 was compared to fish oil. The synbiotic SynΩ3 comprising Bacillus megaterium DSM 32963 and n-3 PUFA salts significantly increased circulating SPM precursor levels, including 18-hydroxy-eicosapentaenoic acid (18-HEPE) plus 5-HEPE, which was not achieved to this extent by fish oil with a similar n-3 PUFA content. Omega-3 indices were increased slightly by both SynΩ3 and fish oil. These findings suggest reconsidering conventional n-3 PUFA supplementation and testing the effectiveness of SynΩ3 particularly in conditions related to inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Evonik Operations GmbH, Rodenbacher Chaussee 4, 63457 Hanau, Germany.
- BioTeSys GmbH, Schelztorstrasse 54-56, 73728 Esslingen, Germany.
- Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University Jena, 07743 Jena, Germany.
- Jena Center for Soft Matter (JCSM), Friedrich Schiller University Jena, 07743 Jena, Germany.
- Department of Mathematics, Natural and Economic Sciences, Ulm University of Applied Sciences, 89081 Ulm, Germany.
ORCID-Profile: Paul M Jordan, Oliver Werz, Manfred Wilhelm, Christiane Schön
Förderung
- Evonik Operations GmbH
Zitieren
APA
Speckmann, B., Wagner, T., Jordan, P. M., Werz, O., Wilhelm, M., Tom Dieck, H., & Schön, C. (2024). Synbiotic Bacillus megaterium DSM 32963 and n-3 PUFA Salt Composition Elevates Pro-Resolving Lipid Mediator Levels in Healthy Subjects: A Randomized Controlled Study. Nutrients. https://doi.org/10.3390/nu16091354
Vancouver
Speckmann B, Wagner T, Jordan PM, Werz O, Wilhelm M, Tom Dieck H, et al. Synbiotic Bacillus megaterium DSM 32963 and n-3 PUFA Salt Composition Elevates Pro-Resolving Lipid Mediator Levels in Healthy Subjects: A Randomized Controlled Study. Nutrients. 2024. doi:10.3390/nu16091354
BibTeX
@article{Speckmann2024,
author = {Speckmann, Bodo and Wagner, Tanja and Jordan, Paul M and Werz, Oliver and Wilhelm, Manfred and Tom Dieck, Heike and Schön, Christiane},
title = {Synbiotic Bacillus megaterium DSM 32963 and n-3 PUFA Salt Composition Elevates Pro-Resolving Lipid Mediator Levels in Healthy Subjects: A Randomized Controlled Study},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16091354}
}
EUVIMED